Cargando…

A Comprehensive Characterization of Stemness in Cell Lines and Primary Cells of Pancreatic Ductal Adenocarcinoma

The aim of this study is to provide a comprehensive characterization of stemness in pancreatic ductal adenocarcinoma (PDAC) cell lines. Seventeen cell lines were evaluated for the expression of cancer stem cell (CSC) markers. The two putative pancreatic CSC phenotypes were expressed heterogeneously...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ferrara, Benedetta, Dugnani, Erica, Sordi, Valeria, Pasquale, Valentina, Pellegrini, Silvia, Reni, Michele, Balzano, Gianpaolo, Piemonti, Lorenzo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9503169/ https://www.ncbi.nlm.nih.gov/pubmed/36142575 http://dx.doi.org/10.3390/ijms231810663

Ejemplares similares

Effect of Diabetes on Survival after Resection of Pancreatic Adenocarcinoma. A Prospective, Observational Study
por: Balzano, Gianpaolo, et al.
Publicado: (2016)

Circulating Chromogranin A Is Cleaved Into Vasoregulatory Fragments in Patients With Pancreatic Ductal Adenocarcinoma
por: Reni, Michele, et al.
Publicado: (2020)

B lymphocytes contribute to stromal reaction in pancreatic ductal adenocarcinoma
por: Minici, Claudia, et al.
Publicado: (2020)

The potential and challenges of alternative sources of β cells for the cure of type 1 diabetes
por: Cito, Monia, et al.
Publicado: (2018)

The personalized medicine for pancreatic ductal adenocarcinoma patients: The oncologist perspective
por: Peretti, Umberto, et al.
Publicado: (2017)

Innate Immunity Mediated Inflammation and Beta Cell Function: Neighbors or Enemies?
por: Citro, Antonio, et al.
Publicado: (2021)

Response to: Comment on: Pancreatectomy With Islet-Autotransplantation as Alternative for Pancreato-Duodenectomy in Patients With a High-Risk for Postoperative Pancreatic Fistula: The Jury Is Still Out
por: Balzano, Gianpaolo, et al.
Publicado: (2023)

Differentiation of Sendai Virus-Reprogrammed iPSC into β Cells, Compared with Human Pancreatic Islets and Immortalized β Cell Line
por: Pellegrini, Silvia, et al.
Publicado: (2018)

Proposal for a New Pathologic Prognostic Index After Neoadjuvant Chemotherapy in Pancreatic Ductal Adenocarcinoma (PINC)
por: Redegalli, M., et al.
Publicado: (2022)

EUS-guided ablation with the HybridTherm Probe as second-line treatment in patients with locally advanced pancreatic ductal adenocarcinoma: A case–control study
por: Testoni, Sabrina Gloria Giulia, et al.
Publicado: (2022)

Mast cells in pancreatic ductal adenocarcinoma
por: Chang, David Z.
Publicado: (2012)

Comment on Total Pancreatectomy With Islet Autotransplantation as an Alternative to High-Risk Pancreatojejunostomy After Pancreaticoduodenectomy: A Prospective Randomized Trial
por: Balzano, Gianpaolo, et al.
Publicado: (2023)

A preclinical evaluation of pemetrexed and irinotecan combination as second-line chemotherapy in pancreatic cancer
por: Mercalli, A, et al.
Publicado: (2007)

Comparative Characterization of Stroma Cells and Ductal Epithelium in Chronic Pancreatitis and Pancreatic Ductal Adenocarcinoma
por: Helm, Ole, et al.
Publicado: (2014)

Targeting dendritic cells in pancreatic ductal adenocarcinoma
por: Deicher, Anton, et al.
Publicado: (2018)

Cancer Stem Cells in Pancreatic Ductal Adenocarcinoma
por: Bubin, Roman, et al.
Publicado: (2023)

Autologous Pancreatic Islet Transplantation in Human Bone Marrow
por: Maffi, Paola, et al.
Publicado: (2013)

Strategies to Improve the Safety of iPSC-Derived β Cells for β Cell Replacement in Diabetes
por: Pellegrini, Silvia, et al.
Publicado: (2022)

Imaging diagnosis and staging of pancreatic ductal adenocarcinoma: a comprehensive review
por: Elbanna, Khaled Y., et al.
Publicado: (2020)

Treating iPSC-Derived β Cells with an Anti-CD30 Antibody–Drug Conjugate Eliminates the Risk of Teratoma Development upon Transplantation
por: Pellegrini, Silvia, et al.
Publicado: (2022)

Phase 1B trial of Nab-paclitaxel plus gemcitabine, capecitabine, and cisplatin (PAXG regimen) in patients with unresectable or borderline resectable pancreatic adenocarcinoma
por: Reni, Michele, et al.
Publicado: (2016)

The Dual Role of Necroptosis in Pancreatic Ductal Adenocarcinoma
por: Giansante, Valentina, et al.
Publicado: (2023)

Mimics of pancreatic ductal adenocarcinoma
por: Al-Hawary, Mahmoud M., et al.
Publicado: (2013)

Pancreatic ductal adenocarcinoma staging
por: Al-Hawary, Mahmoud M., et al.
Publicado: (2013)

Syndecans and Pancreatic Ductal Adenocarcinoma
por: Betriu, Nausika, et al.
Publicado: (2021)

Models of pancreatic ductal adenocarcinoma
por: Dennaoui, Rayane, et al.
Publicado: (2021)

Prognosis of Upfront Surgery for Pancreatic Cancer: A Systematic Review and Meta-Analysis of Prospective Studies
por: Pecorelli, Nicolò, et al.
Publicado: (2022)

The Extracellular Matrix in Pancreatic Cancer: Description of a Complex Network and Promising Therapeutic Options
por: Ferrara, Benedetta, et al.
Publicado: (2021)

Subtypes of pancreatic stellate cells and distant metastasis of pancreatic ductal adenocarcinoma
por: Fan, Yuhui, et al.
Publicado: (2020)

A Comprehensive Review of the Current and Future Role of the Microbiome in Pancreatic Ductal Adenocarcinoma
por: Merali, Nabeel, et al.
Publicado: (2022)

Locally Advanced Pancreatic Ductal Adenocarcinoma: Challenges and Progress
por: Barcellini, Amelia, et al.
Publicado: (2020)

Pancreatic Ductal Adenocarcinoma Associated with Autoimmune Pancreatitis
por: Pezzilli, Raffaele, et al.
Publicado: (2011)

Pancreatic Ductal Adenocarcinoma and Nutrition: Exploring the Role of Diet and Gut Health
por: Gualtieri, Paola, et al.
Publicado: (2023)

Immunomodulatory Effects of Endoscopic Ultrasound-Guided Thermal Ablation in Patients with Pancreatic Ductal Adenocarcinoma
por: Testoni, Sabrina Gloria Giulia, et al.
Publicado: (2023)

Comparative Proteomic Profiling of Pancreatic Ductal Adenocarcinoma Cell Lines
por: Kim, Yikwon, et al.
Publicado: (2014)

Crosstalk between Tumor and Stromal Cells in Pancreatic Ductal Adenocarcinoma
por: Sperb, Nadine, et al.
Publicado: (2020)

Dissecting cell-type-specific metabolism in pancreatic ductal adenocarcinoma
por: Lau, Allison N, et al.
Publicado: (2020)

FAK inhibition radiosensitizes pancreatic ductal adenocarcinoma cells in vitro
por: Mohamed, A. Allam, et al.
Publicado: (2020)

The Role of Stellate Cells in Pancreatic Ductal Adenocarcinoma: Targeting Perspectives
por: Wu, Yang, et al.
Publicado: (2021)

The Immune Checkpoint Landscape in Tumor Cells of Pancreatic Ductal Adenocarcinoma
por: Loch, Florian N., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_lf4hffbh2n6dd9blf8iut4i46b